Reckitt Benckiser pays $1.4 billion in opioid settlement

LONDON — Consumer products company Reckitt Benckiser says it will pay $1.4 billion to resolve U.S. investigations into the marketing of an anti-addiction drug by a subsidiary.

The company said Thursday it reached agreements with the U.S. Department of Justice and the Federal Trade Commission.

The government alleged that an ex-Reckitt subsidiary sought to increase prescriptions for Suboxone Film by deceiving health care providers into believing the drug was safer than other opioid addiction treatments.

Suboxone Film was marketed by RB's former prescription business Indivior, which was spun off in 2014.

The company says it "acted lawfully at all times and expressly denies all allegations that it engaged in any wrongful conduct" but the settlement was in the best interest of RB and shareholders.

It said the settlement would prevent uncertainty and distraction from continued investigations.

Must Read

Fans mourn pop's George Michael as charities...

Dec 26, 2016

Fans are mourning the death of pop star George Michael as British charities praise his generosity

Knighthoods for Murray and Farah in New Year's...

Dec 30, 2016

Andy Murray received a knighthood in Queen Elizabeth II's New Year's Honors list on Friday,...

Queen Elizabeth II attends church after missing 2...

Jan 8, 2017

Queen Elizabeth II has attended church near her Sandringham estate, after missing the previous two...

Britain to mark Queen Elizabeth II's record...

Feb 5, 2017

Queen Elizabeth II is poised for another historic milestone, an unprecedented 65 years on the throne

AP Interview: Depression hits when soccer career...

Feb 6, 2017

On the training pitches at Arsenal is where Jason Brown feels at peace

Sign up now!